May 11, 2020 / 12:25 PM / 19 days ago

BRIEF-Zynerba Pharmaceuticals Reports First Quarter 2020 Results

May 11 (Reuters) - Zynerba Pharmaceuticals Inc:

* ZYNERBA PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

* Q1 LOSS PER SHARE $0.53

* Q1 EARNINGS PER SHARE ESTIMATE $-0.50 — REFINITIV IBES DATA

* ZYNERBA - BELIEVES CASH RUNWAY SUFFICIENT TO FUND OPERATIONS BEYOND EXPECTED NDA SUBMISSION, POTENTIAL APPROVAL OF ZYGEL IN FXS & INTO H2 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below